U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Purchased by Cetera Investment Advisers

Cetera Investment Advisers grew its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 10.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,232 shares of the company’s stock after purchasing an additional 774 shares during the period. Cetera Investment Advisers owned approximately 0.05% of U.S. Physical Therapy worth $596,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of USPH. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of U.S. Physical Therapy in the fourth quarter worth about $39,000. Fifth Third Bancorp increased its stake in shares of U.S. Physical Therapy by 34.6% in the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company’s stock worth $75,000 after purchasing an additional 265 shares during the period. Lazard Asset Management LLC acquired a new stake in U.S. Physical Therapy during the fourth quarter worth about $84,000. Aquatic Capital Management LLC grew its position in U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock worth $115,000 after buying an additional 198 shares in the last quarter. Finally, First Horizon Advisors Inc. boosted its holdings in U.S. Physical Therapy by 35.0% during the first quarter. First Horizon Advisors Inc. now owns 1,929 shares of the company’s stock valued at $140,000 after purchasing an additional 500 shares in the last quarter.

Analyst Ratings Changes

A number of equities research analysts have weighed in on USPH shares. Barrington Research lifted their price objective on U.S. Physical Therapy from $98.00 to $103.00 and gave the company an “outperform” rating in a report on Friday, August 8th. Zacks Research raised U.S. Physical Therapy to a “hold” rating in a report on Friday, August 8th. JMP Securities reaffirmed a “market outperform” rating and set a $113.00 price objective on shares of U.S. Physical Therapy in a report on Tuesday, April 22nd. Finally, Wall Street Zen raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, U.S. Physical Therapy currently has an average rating of “Moderate Buy” and an average target price of $110.25.

U.S. Physical Therapy Stock Down 0.3%

Shares of USPH opened at $85.72 on Friday. The company has a market capitalization of $1.30 billion, a P/E ratio of 37.43, a PEG ratio of 4.39 and a beta of 1.45. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.17. U.S. Physical Therapy, Inc. has a one year low of $62.77 and a one year high of $101.19. The business’s 50 day simple moving average is $77.56 and its 200-day simple moving average is $77.03.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Wednesday, August 6th. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%. The business had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. During the same period in the previous year, the business earned $0.73 EPS. U.S. Physical Therapy’s revenue was up 18.0% compared to the same quarter last year. As a group, sell-side analysts predict that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 12th. Shareholders of record on Friday, August 22nd will be given a dividend of $0.45 per share. The ex-dividend date is Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.1%. U.S. Physical Therapy’s payout ratio is presently 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the company’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the completion of the sale, the chief operating officer owned 22,246 shares in the company, valued at approximately $1,925,836.22. The trade was a 7.45% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Nancy Ham sold 400 shares of the business’s stock in a transaction on Thursday, June 12th. The shares were sold at an average price of $78.01, for a total transaction of $31,204.00. Following the completion of the transaction, the director directly owned 2,594 shares of the company’s stock, valued at $202,357.94. This trade represents a 13.36% decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.